We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$12.4B
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+4.41%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$11.1B
AUM Growth
-$771M
(-6.5%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-9.11%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,240
New
103
Increased
332
Reduced
508
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRS
Verso Corporation
VRS
|
+$18.6M |
| 2 |
Designer Brands
DBI
|
+$15.6M |
| 3 |
G-III Apparel Group
GIII
|
+$14.6M |
| 4 |
Alliance Resource Partners
ARLP
|
+$14.4M |
| 5 |
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$72.7M |
| 2 |
CIR
CIRCOR International, Inc
CIR
|
+$40.1M |
| 3 |
CRAY
Cray, Inc.
CRAY
|
+$26.5M |
| 4 |
Vishay Intertechnology
VSH
|
+$23.6M |
| 5 |
ManpowerGroup
MAN
|
+$23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 29.26% |
| 2 | Technology | 17.08% |
| 3 | Financials | 13.64% |
| 4 | Consumer Discretionary | 12.84% |
| 5 | Materials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
RBB Bancorp
RBB
$451M
| $25K | ﹤0.01% |
1,283
-25
| -2% | -$483 |
|
1102
Enanta Pharmaceuticals
ENTA
$382M
| $24K | ﹤0.01% |
280
+5
| +2% | +$450 |
|
1103
Northeast Bank
NBN
$1.14B
| $24K | ﹤0.01% |
+865
| New | +$18.3K |
|
1104
The Bancorp
TBBK
$2.05B
| $24K | ﹤0.01% |
2,691
-352
| -12% | -$3.24K |
|
|
SCPL
1105
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $24K | ﹤0.01% |
+1,757
| New | +$26K |
|
1106
Radiant Logistics
RLGT
$384M
| $23K | ﹤0.01% |
+3,757
| New | +$24.5K |
|
1107
First Internet Bancorp
INBK
$250M
| $22K | ﹤0.01% |
1,023
-200
| -16% | -$4.26K |
|
1108
PCB Bancorp
PCB
$393M
| $22K | ﹤0.01% |
1,263
-66
| -5% | -$1.15K |
|
1109
Alector
ALEC
$247M
| $21K | ﹤0.01% |
+1,103
| New | +$22.4K |
|
1110
Omega Flex
OFLX
$263M
| $21K | ﹤0.01% |
271
-39
| -13% | -$3.28K |
|
|
TBCH
1111
Turtle Beach Corp
TBCH
$221M
| $21K | ﹤0.01% |
+1,817
| New | +$19.2K |
|
|
HSKA
1112
DELISTED
Heska Corp
HSKA
| $21K | ﹤0.01% |
244
-9
| -4% | -$702 |
|
|
CTO
1113
CTO Realty Growth
CTO
$782M
| $20K | ﹤0.01% |
1,205
-118
| -9% | -$1.93K |
|
1114
FS Bancorp
FSBW
$345M
| $20K | ﹤0.01% |
788
-32
| -4% | -$800 |
|
1115
OP Bancorp
OPBK
$230M
| $20K | ﹤0.01% |
+1,872
| New | +$18.1K |
|
|
RVLT
1116
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
| $20K | ﹤0.01% |
81,200
| – | – |
|
1117
Collegium Pharmaceutical
COLL
$743M
| $19K | ﹤0.01% |
1,468
+373
| +34% | +$4.99K |
|
|
FONR
1118
DELISTED
Fonar
FONR
| $19K | ﹤0.01% |
+890
| New | +$18.2K |
|
1119
LifeVantage
LFVN
$78.3M
| $19K | ﹤0.01% |
1,433
+206
| +17% | +$2.45K |
|
1120
SIGA Technologies
SIGA
$226M
| $19K | ﹤0.01% |
3,317
+250
| +8% | +$1.38K |
|
|
PRNB
1121
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $18K | ﹤0.01% |
532
-74
| -12% | -$2.31K |
|
1122
Winmark
WINA
$1.08B
| $15K | ﹤0.01% |
86
-3
| -3% | -$537 |
|
|
PES
1123
DELISTED
Pioneer Energy Services Corp.
PES
| $15K | ﹤0.01% |
57,500
-48,100
| -46% | -$52.6K |
|
1124
iRadimed
IRMD
$1.06B
| $14K | ﹤0.01% |
662
+46
| +7% | +$1.08K |
|
|
CCRD
1125
DELISTED
CoreCard
CCRD
| $12K | ﹤0.01% |
+431
| New | +$14.3K |
|
Similar funds
JF
WRCM
LC
AIM
SC
ERSOT
BAMF
Royce & Associates's Q2 2019 Portfolio in Review
As of Q2 2019, Royce & Associates held 1,240 positions worth $11.1B, down 6.5% from $11.8B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Royce & Associates withdrew a net $1.01B in Q2 2019, closing 87 positions and reducing 508 holdings. Its most notable exit was Universal Corp, an estimated $17.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 29% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
Against the trend, Royce & Associates opened a new position in G-III Apparel Group worth $12.6M.
- Royce & Associates's largest Q2 2019 buy was G-III Apparel Group: 426,975 shares worth $12.6M.
- Royce & Associates added most to Verso Corporation in Q2 2019, an estimated $18.6M increase.
- Royce & Associates's biggest Q2 2019 reduction was Medidata Solutions, Inc., cutting an estimated $72.7M.
- Royce & Associates fully exited Universal Corp in Q2 2019, selling an estimated $17.7M.
- Royce & Associates's ten largest holdings make up 9.6% of its $11.1B portfolio in Q2 2019.
- Royce & Associates opened 103 new positions and closed 87 in Q2 2019.
- Royce & Associates's portfolio value fell 6.5% quarter-over-quarter to $11.1B.
Based on Royce & Associates's 13F filing for Q2 2019, filed 12 Aug 2019.